Abstract
Cocaine, as an indirect dopamine agonist, induces selective behavioral and physiological events such as hyperlocomotion and dopamine release. These changes are considered as consequences of cocaine-induced molecular adaptation such as CREB and c-Fos. Recently, methanolic extracts from licorice was reported to decrease cocaine-induced dopamine release and c-Fos expression in the nucleus accumbens. In the present study, we investigated the effects of liquiritigenin (LQ), a main compound of licorice, on acute cocaine-induced behavioral and molecular changes in rats. LQ attenuated acute cocaine-induced hyperlocomotion in dose-dependent manner. In addition, LQ inhibited CREB phosphorylation and c-Fos expression in the striatum and the nucleus accumbens induced by acute cocaine. Results provide strong evidence that LQ effectively attenuates the acute behavioral effects of cocaine exposure and prevents the induction of selective neuroadaptive changes in dopaminergic signaling pathways. Further investigation of LQ from licorice extract might provide a novel therapeutic strategy for the treatment of cocaine addiction.
Keywords: Liquiritigenin, cocaine, hyperlocomotion, CREB, c-Fos, nucleus accumbens, striatum, postsynaptic D1/D2-like dopamine, postsynaptic neuronal
Current Neuropharmacology
Title: Liquiritigenin Decreases Selective Molecular and Behavioral Effects of Cocaine in Rodents
Volume: 9 Issue: 1
Author(s): E. Y. Jang, M. Hwang, S. S. Yoon, J. R. Lee, K. J. Kim, H.-C. Kim and C. H. Yang
Affiliation:
Keywords: Liquiritigenin, cocaine, hyperlocomotion, CREB, c-Fos, nucleus accumbens, striatum, postsynaptic D1/D2-like dopamine, postsynaptic neuronal
Abstract: Cocaine, as an indirect dopamine agonist, induces selective behavioral and physiological events such as hyperlocomotion and dopamine release. These changes are considered as consequences of cocaine-induced molecular adaptation such as CREB and c-Fos. Recently, methanolic extracts from licorice was reported to decrease cocaine-induced dopamine release and c-Fos expression in the nucleus accumbens. In the present study, we investigated the effects of liquiritigenin (LQ), a main compound of licorice, on acute cocaine-induced behavioral and molecular changes in rats. LQ attenuated acute cocaine-induced hyperlocomotion in dose-dependent manner. In addition, LQ inhibited CREB phosphorylation and c-Fos expression in the striatum and the nucleus accumbens induced by acute cocaine. Results provide strong evidence that LQ effectively attenuates the acute behavioral effects of cocaine exposure and prevents the induction of selective neuroadaptive changes in dopaminergic signaling pathways. Further investigation of LQ from licorice extract might provide a novel therapeutic strategy for the treatment of cocaine addiction.
Export Options
About this article
Cite this article as:
Y. Jang E., Hwang M., S. Yoon S., R. Lee J., J. Kim K., Kim H.-C. and H. Yang C., Liquiritigenin Decreases Selective Molecular and Behavioral Effects of Cocaine in Rodents, Current Neuropharmacology 2011; 9 (1) . https://dx.doi.org/10.2174/157015911795017371
DOI https://dx.doi.org/10.2174/157015911795017371 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Allosteric Enhancers of A1 Adenosine Receptors: State of the Art and New Horizons for Drug Development
Current Medicinal Chemistry Editorial (Thematic Issue: Perinatal Stem Cells Patents and Applications: Regenerative Medicine, Tissue Repair, Immune Modulation)
Recent Patents on Regenerative Medicine Actigraphy for Assessing Light Effects on Sleep and Circadian Activity Rhythm in Alzheimer's Dementia: A Narrative Review
Current Alzheimer Research Analgesia in PACU: Indications, Monitoring, Complications
Current Drug Targets Influence of the Bystander Effect on HSV-tk / GCV Gene Therapy. A Review.
Current Gene Therapy Dysregulation of RNA Mediated Gene Expression in Motor Neuron Diseases
CNS & Neurological Disorders - Drug Targets Functional Neuroimaging of Sleep Disorders
Current Pharmaceutical Design Nitric Oxide and Protection against Cardiac Ischemia
Current Pharmaceutical Design Tamoxifen as a Powerful Neuroprotectant in Experimental Stroke and Implications for Human Stroke Therapy
Recent Patents on CNS Drug Discovery (Discontinued) Unique Coronary Artery Disease Differences in Women as Related to Revascularization
Current Medicinal Chemistry Insights into the Drug Repositioning Applied to the Alzheimer's Disease Treatment and Future Perspectives
Current Alzheimer Research Ketamine: New Indications for an Old Drug
Current Drug Targets An Overview of Prospective Drugs for Type 1 and Type 2 Diabetes
Current Drug Targets Tin as an Emerging Surrogate for Lead-free Perovskite Solar Cells
Nanoscience & Nanotechnology-Asia Formation Mechanism of Insulin Fibrils and Structural Aspects of the Insulin Fibrillation Process
Current Protein & Peptide Science Theoretical Study of Monoamine Oxidase B Inhibitors as Drug Candidates for Treatment of Parkinson’s Disease
Central Nervous System Agents in Medicinal Chemistry Therapeutic Approach to Multiple Sclerosis by Novel Oral Drugs
Recent Patents on Inflammation & Allergy Drug Discovery Effects of Memantine on Event-Related Potentials in Alzheimer’s Disease Under Donepezil Treatment
Neuroscience and Biomedical Engineering (Discontinued) Neuropsychological Findings in Obsessive-Compulsive Disorder and its Potential Implications for Treatment
Current Psychiatry Reviews Progress in the Development of Nonpeptidomimetic BACE 1 Inhibitors for Alzheimers Disease
Current Medicinal Chemistry